Sonnet BioTherapeutics Holdings, Inc. (SONN) News
Filter SONN News Items
SONN News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
SONN News Highlights
- SONN's 30 day story count now stands at 2.
- Over the past 7 days, the trend for SONN's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
Latest SONN News From Around the Web
Below are the latest news stories about SONNET BIOTHERAPEUTICS HOLDINGS INC that investors may wish to consider to help them evaluate SONN as an investment opportunity.
Sonnet BioTherapeutics Announces Publication Demonstrating Suitability of SON-1210, the First Albumin-binding Bifunctional IL-12/IL-15 Fusion Protein, for Solid Tumor ImmunotherapyPRINCETON, NJ / ACCESSWIRE / December 21, 2023 / Sonnet BioTherapeutics Holdings, Inc., (NASDAQ:SONN) a clinical-stage company developing targeted immunotherapeutic drugs for cancer, announced today the publication of extensive preclinical data on ... |
Sonnet BioTherapeutics Provides Fiscal Year 2023 Business and Financial UpdatePRINCETON, NJ / ACCESSWIRE / December 14, 2023 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical company developing innovative targeted biologic drugs focused on oncology, announced today its financial ... |
Sonnet BioTherapeutics Provides Fiscal Year 2023 Business OverviewFollowing the recent completion of a $4.55 million financing, Sonnet projects cash runway into the calendar year third quarter of 2024The company is focused on its business development initiatives and anticipates being able to provide an update in ... |
Why Is Sonnet BioTherapeutics (SONN) Stock Down 33% Today?Sonnet BioTherapeutics stock is dropping on Wednesday after the company revealed the pricing of a public offering for SONN shares. |
EVGO Stock Slips as TD Cowen Downgrades EVgoEVgo stock is taking a beating on Wednesday as investors in the EV charging company deal with a downgrade and price cut. |
Why Is BioXcel Therapeutics (BTAI) Stock Up 42% Today?BioXcel Therapeutics stock is rising on Wednesday as investors in BTAI stock react to results from an audit on a clinical trial. |
Why Is InMed Pharmaceuticals (INM) Stock Down 25% Today?InMed Pharmaceuticals stock is falling on Wednesday after shares of INM underwent a massive rally on Tuesday alongside study results. |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on WednesdayPre-market stock movers are a hot topic on Wednesday and we're offering all the details that investors need to know about this morning. |
Sonnet BioTherapeutics Announces Pricing of $4.55 Million Underwritten Public OfferingPRINCETON, NJ / ACCESSWIRE / October 25, 2023 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("we," "us," "our," "Sonnet" or the "Company"), a clinical-stage company developing innovative targeted biologic drugs, today announced the pricing ... |
Sonnet BioTherapeutics Announces Abstract Accepted for Presentation by a Key Opinion Leader at the 2023 Connective Tissue Oncology Society (CTOS) Annual MeetingPRINCETON, NJ / ACCESSWIRE / October 17, 2023 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical company developing innovative targeted biologic drugs, announced today that previously announced interim ... |